Journal Information
Vol. 101. Issue 6.
Pages 419-420 (1 December 2024)
Vol. 101. Issue 6.
Pages 419-420 (1 December 2024)
Images in Paediatrics
Full text access
Oral blistering mucositis in adolescent
Mucositis oral ampollosa en adolescente
Visits
397
Jana Codina Barbosaa,
Corresponding author
jana.codina@sjd.es

Corresponding author.
, Alicia Suñé Aznareza, Carla Donado-Mazarrón Garciaa, José Martínez Hernandob
a Servicio de Pediatría, Hospital Sant Joan de Déu, Universidad de Barcelona, Barcelona, Spain
b Área de Urgencias, Hospital Sant Joan de Déu, Esplugues de Llobregat, Barcelona, Spain
This item has received
Article information
Full Text
Bibliography
Download PDF
Statistics
Figures (3)
Show moreShow less
Full Text

We describe the case of a female patient aged 14 years, with no history or disease of interest, who presented with bilateral conjunctival hyperaemia (Fig. 1) and painful blisters measuring 3 cm in diameter over the lips, soft palate and gums (Fig. 2). The patient was afebrile and reported not having taken any pharmaceuticals.

Figure 1.

Conjunctival hyperaemia.

(0.09MB).
Figure 2.

Oral mucositis.

(0.12MB).

The blood tests performed due to suspicion of reactive infectious mucocutaneous eruption revealed mild neutrophilia, a C-reactive protein level of 18.5 mg/L and positive IgM and IgG antibodies for Mycoplasma pneumoniae. The polymerase chain reaction test in a nasopharyngeal aspirate sample was negative for M. pneumoniae, Chlamydia pneumoniae, influenza and other viruses.

Due to pain and refusal to eat, the patient was admitted for analgesia and intravenous therapy. The isolated presence of IgM antibodies does not suffice for diagnosis of Mycoplasma infection, as it can remain elevated for months.1 However, a negative PCR test on nasopharyngeal aspirate does not rule out this aetiology (sensitivity of 45%–56%).1 In the absence of an alternative diagnosis, given the presence of compatible symptoms, treatment was initiated with oral azithromycin at a dose of 10 mg/kg and methylprednisolone at a dose of 40 mg/day for 5 days.

During the hospital stay, the patient developed red-rimmed bull’s-eye lesions on the chest and back (Fig. 3). Due to the presence of diffuse punctate keratitis, the patient received treatment with an ophthalmic corticosteroid ointment and an antibiotic, which achieved an excellent outcome.

Figure 3.

Erythema multiforme.

(0.23MB).

The mucocutaneous eruption induced by M. pneumoniae is characterised by severe mucositis predominantly affecting the oral cavity, conjunctiva and genital mucosa. It is now considered a distinct disease outside of Stevens-Johnson syndrome or toxic epidermal necrolysis on account of its aetiology, treatment and excellent prognosis.2,3 In the case presented here, there was a high level of suspicion due to the epidemiological context, compatible clinical manifestations and favourable outcome of treatment, in addition to the serological test results.

Funding

This research did not receive any external funding.

References
[1]
WA Goycochea-Valdivia, J Ares Alvarez, AJ Conejo Fernández, AB Jiménez Jiménez, I Maté Cano, T de Jesús Reinoso Lozano, et al.
Posicionamiento de la Sociedad Española de Infectología Pediátrica sobre el diagnóstico y tratamiento de la infección por Mycoplasma pneumoniae.
Anal Pediatr, 101 (2024), pp. 46-57
[2]
M. Martínez Pérez, A. Imbernón Moya, A. Lobato Berezo, M. Churruca Grijelmo.
Exantema mucocutáneo inducido por Mycoplasma pneumoniae: ¿un nuevo síndrome separado del eritema multiforme? Un nuevo caso y revisión de la literatura e.
Actas Dermosifiliogr, 107 (2016), pp. e47-e51
[3]
R Berzosa López, MA Carro Rodríguez, M de la Parte Cancho, M Mora Sitjà, R Piñeiro Pérez.
Las mil y una caras del Mycoplasma.
Rev Pediatr Aten Primaria, 23 (2021), pp. 297-299
Copyright © 2024. Asociación Española de Pediatría
Download PDF
Idiomas
Anales de Pediatría (English Edition)
Article options
Tools
es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?